Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock

25.0600.00Vol 12.40K1Y Perf 13.91%
Apr 12th, 2021 15:07 DELAYED
BID16.34 ASK0.0000
Open25.07 Previous Close25.06
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     60.18
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★     58.71
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★★★     69.17
Market Cap- 
Earnings Rating
Price Range Ratio 52W %
37.08 
Earnings Date
-

Today's Price Range

25.0425.07

52W Range

21.0031.95

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.00%
1 Month
-0.52%
3 Months
-15.05%
6 Months
-6.32%
1 Year
13.91%
3 Years
0.50%
5 Years
41.58%
10 Years
-

TickerPriceChg.Chg.%
CDMOP25.060.00000.00
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume12.40K
Shares Outstanding0
Trades Count49
Dollar Volume134.55K
Avg. Volume11.02K
Avg. Weekly Volume14.18K
Avg. Monthly Volume16.25K
Avg. Quarterly Volume11.46K

Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock (NASDAQ: CDMOP) stock closed at 25.06 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 12.40K shares and market capitalization of 0.0000. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 227 people. Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock CEO is Nicholas S. Green.

The one-year performance of Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock stock is 13.91%, while year-to-date (YTD) performance is -8.91%. CDMOP stock has a five-year performance of 41.58%. Its 52-week range is between 21 and 31.95, which gives CDMOP stock a 52-week price range ratio of 37.08%

Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock currently has a PE ratio of -, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of 0.51, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -0.16%, a ROC of -0.35% and a ROE of -0.34%. The company’s profit margin is 4.83%, its EBITDA margin is 9.50%, and its revenue ttm is $80.81 Million , which makes it $49.04 revenue per share.

Of the last four earnings reports from Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock’s next earnings report date is -.

The consensus rating of Wall Street analysts for Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock has a dividend yield of 10.47% with a dividend per share of $2.63 and a payout ratio of -%.

Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock has a Sell technical analysis rating based on Technical Indicators (ADX : 11.80, ATR14 : 0.89, CCI20 : -47.34, Chaikin Money Flow : 0.25, MACD : -1.15, Money Flow Index : 23.46, ROC : -0.08, RSI : 28.07, STOCH (14,3) : 35.71, STOCH RSI : 0.00, UO : 57.72, Williams %R : -64.29), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on development and current Good Manufacturing Practices (cGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

CEO: Nicholas S. Green

Telephone: +1 714 508-6100

Address: 2642 Michelle Drive, Tustin 92780, CA, US

Number of employees: 227

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

50%50%

News

Stocktwits